Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: Development of a Prediction Model for Differential Diagnosis Between Intestinal Tuberculosis and Crohn's Disease
A completed clinical trial updated the development of a prediction model to differentiate intestinal tuberculosis from Crohn's disease. The …
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: The Impact of "Crohn's Disease-TReatment-with-EATing" Diet and Exclusive Enteral Nutrition on Healthy Gut Bacteria [NA]
A completed clinical trial from the University of Glasgow evaluating the impact of an exclusive enteral nutrition diet on gut microbiota in …
-
CLINICAL_TRIALS trial_result · 2016-05-25Clinical Trial Update: Bacteriotherapy in Pediatric Inflammatory Bowel Disease [Phase 1]
This is a Phase 1 pediatric trial evaluating bacteriotherapy for inflammatory bowel disease, including Crohn's disease and ulcerative coliti…
-
CLINICAL_TRIALS trial_result · 2016-05-19Clinical Trial Update: Laparoscopy Combined With Enhanced Recovery Pathway [NA]
This Clinical Trial Update discusses a study evaluating laparoscopy combined with an enhanced recovery pathway for Crohn's disease. The curr…
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Two Treatment Modules in Chinese Subjects With Moderate to Severe Crohn's Disease [Phase 2]
A Phase 2 study evaluating pharmacokinetics, safety, and efficacy of two treatment modules in Chinese patients with moderate to severe Crohn…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Evaluation of Health Costs and Resource Utilization [Phase 4]
Phase 4 trial evaluating health costs and resource utilization in ulcerative colitis and Crohn's disease has been terminated.
-
CLINICAL_TRIALS research · 2016-05-12Clinical Trial Update: Thrombin Generation in Crohn's Disease
The document provides an update on a clinical trial examining thrombin generation in Crohn's disease. The study (NCT02445690) is sponsored b…
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants [Phase 3]
A Phase 3 trial assessing mucosal activity to improve prognosis in Crohn's disease patients treated with immunosuppressants has been termina…
-
CLINICAL_TRIALS trial_result · 2016-05-02Clinical Trial Update: Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication Use
A terminated Vanderbilt University clinical trial studied decisional influences on medication use among patients with Crohn's disease and ul…
-
FDA approval · 2016-04-29FDA Approved: BUDESONIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for budesonide. The action reflects changes to the product's labeling…
-
CLINICAL_TRIALS research · 2016-04-28Clinical Trial Update: Early Surgery Versus Conservative Treatment in Patients With Ileocaecal Crohn's Disease [NA]
A clinical trial comparing early surgery to conservative treatment for ileocecal Crohn's disease is ongoing; the status is currently unknown…
-
CLINICAL_TRIALS trial_result · 2016-04-25Clinical Trial Update: Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease
Clinical trial evaluating a biological therapy's effect on biomarkers in untreated Hepatitis C, metastatic melanoma, and Crohn's disease was…
-
CLINICAL_TRIALS withdrawal · 2016-04-15Clinical Trial Update: Autologous Hematopoietic Stem Cell Transplantation for Crohn's Disease Treatment [EARLY_Phase 1]
An early-phase (Phase 1) trial evaluating autologous hematopoietic stem cell transplantation for Crohn's disease has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-04-12Clinical Trial Update: A Study of Adalimumab After Dose Escalation in Japanese Subjects With Crohn's Disease [Phase 3]
Phase 3 trial evaluating adalimumab after dose escalation in Japanese subjects with Crohn's disease; results have been posted.
-
FDA approval · 2016-04-05FDA Approved: INFLECTRA — Original Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved INFLECTRA (infliximab-dyyb) as a biosimilar to infliximab for multiple autoimmune diseases, expanding access to a biologic ther…
-
CLINICAL_TRIALS withdrawal · 2016-04-05Clinical Trial Update: A Crohn's Disease Diet to Reduce Symptoms of Crohn's Disease [NA]
A Johns Hopkins University-sponsored clinical trial investigating a Crohn's disease diet to reduce symptoms has been withdrawn from Clinical…
-
CLINICAL_TRIALS trial_result · 2016-04-01Clinical Trial Update: Harmonic ACE®+7 Shears in Laparoscopic Colectomy [Phase 4]
Phase 4 clinical trial evaluating Harmonic ACE+7 Shears for use in laparoscopic colectomy has completed, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: The Influence of Information Sources on Knowledge and Anxiety in Inflammatory Bowel Disease Patients
This completed clinical trial assessed how different information sources influence knowledge and anxiety among patients with inflammatory bo…
-
CLINICAL_TRIALS research · 2016-03-16Clinical Trial Update: IBDSL Biobank Project. Molecular Markers for Diagnosis and Therapy Response in IBD.
This update describes the IBDSL Biobank Project, which investigates molecular markers for diagnosing inflammatory bowel disease and predicti…
-
CLINICAL_TRIALS research · 2016-03-09Clinical Trial Update: Anal Human Papillomavirus in Inflammatory Bowel Disease Study
Clinical trial update on anal human papillomavirus in inflammatory bowel disease, including ulcerative colitis and Crohn's disease, complete…
-
FDA approval · 2016-03-08FDA Approved: BUDESONIDE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a generic budesonide product under an Original Application (ANDA 204548) for Teva Pharmaceuticals USA, Inc. This marks the appr…
-
CLINICAL_TRIALS trial_result · 2016-03-01Clinical Trial Update: Thalidomide in Treating Crohn's Disease [Phase 2]
Phase 2 clinical trial evaluating thalidomide for Crohn's disease has completed according to the update. No efficacy results are provided in…
-
EMA safety_alert · 2016-02-26EMA confirms recommendations to minimise risk of brain infection PML with Tysabri
EMA confirms recommendations to minimize the risk of progressive multifocal leukoencephalopathy (PML) with Tysabri (natalizumab).
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: Efficacy and Safety of GLPG0634 in Subjects With Active Crohn's Disease [Phase 2]
A Phase 2 trial evaluated GLPG0634 (filgotinib) for efficacy and safety in active Crohn's disease. The study has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: EUS Evaluation of Perianal and Peri-rectal Fistulizing Crohn's Disease With CERTOLIZUMAB Treatment
A terminated clinical trial evaluating certolizumab pegol (Cimzia) for perianal and peri-rectal fistulizing Crohn's disease, using endoscopi…